These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Eg5 Inhibitors Have Contrasting Effects on Microtubule Stability and Metaphase Spindle Integrity. Chen GY; Kang YJ; Gayek AS; Youyen W; Tüzel E; Ohi R; Hancock WO ACS Chem Biol; 2017 Apr; 12(4):1038-1046. PubMed ID: 28165699 [TBL] [Abstract][Full Text] [Related]
3. STLC-resistant cell lines as tools to classify chemically divergent Eg5 targeting agents according to their mode of action and target specificity. Indorato RL; DeBonis S; Kozielski F; Garcia-Saez I; Skoufias DA Biochem Pharmacol; 2013 Nov; 86(10):1441-51. PubMed ID: 24041742 [TBL] [Abstract][Full Text] [Related]
4. Eg5 targeting agents: From new anti-mitotic based inhibitor discovery to cancer therapy and resistance. Garcia-Saez I; Skoufias DA Biochem Pharmacol; 2021 Feb; 184():114364. PubMed ID: 33310050 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the mitotic kinesin Eg5 up-regulates Hsp70 through the phosphatidylinositol 3-kinase/Akt pathway in multiple myeloma cells. Liu M; Aneja R; Liu C; Sun L; Gao J; Wang H; Dong JT; Sarli V; Giannis A; Joshi HC; Zhou J J Biol Chem; 2006 Jun; 281(26):18090-7. PubMed ID: 16627469 [TBL] [Abstract][Full Text] [Related]
6. Morelloflavone as a novel inhibitor of mitotic kinesin Eg5. Ogunwa TH; Taii K; Sadakane K; Kawata Y; Maruta S; Miyanishi T J Biochem; 2019 Aug; 166(2):129-137. PubMed ID: 30785183 [TBL] [Abstract][Full Text] [Related]
7. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5. Maliga Z; Kapoor TM; Mitchison TJ Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373 [TBL] [Abstract][Full Text] [Related]
8. TPX2 Inhibits Eg5 by Interactions with Both Motor and Microtubule. Balchand SK; Mann BJ; Titus J; Ross JL; Wadsworth P J Biol Chem; 2015 Jul; 290(28):17367-79. PubMed ID: 26018074 [TBL] [Abstract][Full Text] [Related]
9. Molecular dissection of the inhibitor binding pocket of mitotic kinesin Eg5 reveals mutants that confer resistance to antimitotic agents. Brier S; Lemaire D; DeBonis S; Forest E; Kozielski F J Mol Biol; 2006 Jul; 360(2):360-76. PubMed ID: 16780877 [TBL] [Abstract][Full Text] [Related]
10. Drug resistance dependent on allostery: A P-loop rigor Eg5 mutant exhibits resistance to allosteric inhibition by STLC. Indorato RL; DeBonis S; Garcia-Saez I; Skoufias DA Front Oncol; 2022; 12():965455. PubMed ID: 36313676 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation by Cdk1 increases the binding of Eg5 to microtubules in vitro and in Xenopus egg extract spindles. Cahu J; Olichon A; Hentrich C; Schek H; Drinjakovic J; Zhang C; Doherty-Kirby A; Lajoie G; Surrey T PLoS One; 2008; 3(12):e3936. PubMed ID: 19079595 [TBL] [Abstract][Full Text] [Related]
12. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5. DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161 [TBL] [Abstract][Full Text] [Related]
13. Kolaflavanone, a biflavonoid derived from medicinal plant Garcinia, is an inhibitor of mitotic kinesin Eg5. Alrazi IMD; Ogunwa TH; Kolawole AO; Elekofehinti OO; Omotuyi OI; Miyanishi T; Maruta S J Biochem; 2021 Dec; 170(5):611-622. PubMed ID: 34264310 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel scaffolds to inhibit human mitotic kinesin Eg5 targeting the second allosteric binding site using in silico methods. Makala H; Ulaganathan V J Recept Signal Transduct Res; 2018 Feb; 38(1):12-19. PubMed ID: 29041840 [TBL] [Abstract][Full Text] [Related]
20. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5. Brier S; Lemaire D; Debonis S; Forest E; Kozielski F Biochemistry; 2004 Oct; 43(41):13072-82. PubMed ID: 15476401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]